SCHEMBL19080118

SCHEMBL19080118

c1cc(-c2ccc3c4ccccc4c4c(oc5ccc6ccccc6c54)c3c2)cc(-c2c3ccccc3c(-c3cccc(-c4cccc5ccccc45)c3)c3ccccc23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.37
PAX8 Q06710 2/20 0.37
ABCG2 Q9UNQ0 2/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1A2 P05177 1/20 0.37
FYN P06241 1/20 0.37
MAPK3 P27361 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
NPC1 O15118 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
RAB9A P51151 1/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079974 0.95 AHR (0.37) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL19079939 0.92 ABCG2 (0.42) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL19080005 0.91 CYP1A1 (0.40) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL19080134 0.89 ABCG2 (0.37) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL16067722 0.88 ALOX5 (0.40) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL19080068 0.87 CYP1A1 (0.35) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL19080054 0.87 ALOX5 (0.37) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL19080126 0.87 CA12 (0.40) CYP1A2CA12CA1CA2CA9
SCHEMBL16067658 0.87 ALOX5 (0.41) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL19079963 0.86 AHR (0.34) AHRPAX8ABCG2CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 AHR 2211/4885PAX8 1759/4885ABCG2 4758/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 AHR 2211/4885PAX8 1759/4885ABCG2 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.